Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-11 Sale |
2023-05-15 4:37 pm |
10x Genomics Inc. | TXG | Mammen Mathai Director |
33,000 | $52.82 | $1,743,086 | 169,745 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-11 Option Award |
2024-06-13 4:22 pm |
N/A N/A |
10x Genomics Inc. | TXG | Mammen Mathai Director |
8,649 | $0 | 180,259 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:40 pm |
N/A 2033-06-14 |
10x Genomics Inc. | TXG | Mammen Mathai Director |
6,526 | $0 | 176,271 (Direct) |
View |
| 2023-05-11 Exercise |
2023-05-15 4:37 pm |
N/A N/A |
10x Genomics Inc. | TXG | Mammen Mathai Director |
200,000 | $1.16 | 169,745 (Direct) |
View |
| 2023-05-11 Exercise |
2023-05-15 4:37 pm |
N/A 2027-06-12 |
10x Genomics Inc. | TXG | Mammen Mathai Director |
200,000 | $0 | 169,745 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:14 pm |
N/A 2031-06-15 |
10x Genomics Inc. | TXG | Mammen Mathai Director |
7,420 | $0 | 8,045 (Direct) |
View |
| 2022-02-14 Option Award |
2022-02-17 06:00 am |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D |
38,736 | $165.89 | 85,329 (Direct) |
View |
| 2022-02-15 Exercise |
2022-02-17 06:00 am |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D |
7,740 | $0 | 85,329 (Direct) |
View |
| 2022-02-15 Tax Withholding |
2022-02-17 06:00 am |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D |
3,366 | $165.89 | 85,329 (Direct) |
View |
| 2022-02-14 Option Award |
2022-02-17 06:00 am |
2025-02-14 N/A |
JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D |
3,922 | $0 | 85,329 (Direct) |
View |
| 2022-02-14 Tax Withholding |
2022-02-15 8:03 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D |
2,335 | $168.85 | 37,560 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-15 8:03 pm |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D |
7,418 | $0 | 37,560 (Direct) |
View |
Ownership |
2022-01-13 4:43 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D |
0 | $0 | 250,624 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 5:50 pm |
N/A 2031-06-11 |
10x Genomics Inc. | TXG | Mammen Mathai Director |
2,188 | $0 | 2,188 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-17 4:29 pm |
N/A 2030-06-15 |
10x Genomics Inc. | TXG | Mammen Mathai Director |
4,432 | $0 | 4,432 (Direct) |
View |